Tucson, AZNCT07851246Now EnrollingIRB Ready

Influenza, Human Clinical Trial in Tucson, AZ

Access cutting-edge influenza, human treatment through this phase 3 clinical trial at a research site in Tucson. Study-provided care at no cost to qualified participants.

Sponsored by GlaxoSmithKline

Quick Self-Assessment

See if you qualify for this Tucson location

Preparing your pre-screening questions…

Expert Care in Tucson

Access influenza, human specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related influenza, human treatment provided free

Apply for This Tucson Location

Check if you qualify for this influenza, human clinical trial in Tucson, AZ

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to Tucson

    Convenient for AZ residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit Tucson site if eligible
  4. 4Begin participation

About This Influenza, Human Study in Tucson

This clinical trial will study an investigational seasonal influenza vaccine in adults 18 to 64 years of age. The vaccine is based on messenger ribonucleic acid, also called mRNA. The main goals of the study are to learn how well the vaccine helps the body make an immune response against influenza and what medical problems participants may have after vaccination. Researchers will also compare immune responses in adults 18 to 64 years of age from this study, with immune responses in adults 65 years of age and older from another study. Participants will receive 1 injection into the upper arm muscle and will be followed for about 6 months.

Sponsor: GlaxoSmithKline

Who Can Participate

Inclusion Criteria

Participants who, in the opinion of the investigator, can and will comply with the requirements of the protocol (e.g., completion of the eDiary, return for follow-up visits, attendance to study contacts, and ability to access and utilize a phone or other electronic communications) independently or with the assistance of a caregiver.
A male or female participant between and including 18 to 64 years of age at the time of study intervention administration
Participants of childbearing potential may be enrolled, if the participant:
has practiced adequate contraception for at least 30 days prior to study intervention administration, and
has a negative urine pregnancy test within 24 hours prior to study intervention administration, and
has agreed to continue adequate contraception for at least 8 weeks after study intervention administration.

Exclusion Criteria

History of test confirmed influenza infection within 180 days prior to study intervention administration.
Confirmed or suspected immunosuppressive or immunodeficient condition, except for stable human immunodeficiency virus infection meeting protocol-defined stability criteria.
History of myocarditis or pericarditis considered causally associated with the administration of an mRNA vaccine.
History of hypersensitivity or allergic reaction to any previous influenza vaccine.
History of hypersensitivity or allergic reaction to any previous mRNA vaccine.
History of Guillain-Barré syndrome (GBS) within 6 weeks of receiving any vaccine.
Acute or unstable chronic conditions as determined by medical history and clinical examination.
Administration of an influenza vaccine in the period starting 180 days before the study intervention administration or planned administration prior to Visit 2 during the study.
Planned administration/administration of prohibited vaccines within protocol-defined time windows before or after study intervention administration.
Use of any investigational or non-registered product (other than the study intervention during the period beginning 30 days before the dose of study intervention (Day -29 to Day 1), or their planned use during the study period.
Chronic administration of immune-modifying drugs (defined as more than 14 consecutive days in total) and/or planned use of long-acting immune modifying treatments at any time up to the end of the study.
Pregnant or lactating female participant.

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Tucson?

Yes, this clinical trial (NCT07851246) has an active research site in Tucson, AZ that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Influenza, Human Treatment Options in Tucson, AZ

If you're searching for influenza, human treatment options in Tucson, AZ, this clinical trial (NCT07851246) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Tucson research site is actively enrolling participants for this phase 3 clinical trial. You'll receive care from experienced influenza, human specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all influenza, human clinical trials near you to find additional studies recruiting in your area.

More Follicular Lymphoma Trials in Tucson, AZ

See all follicular lymphoma clinical trials recruiting in Tucson — not just this study.

Browse Follicular Lymphoma Trials in Tucson →

Browse More Trials by Condition

Follicular Lymphoma TrialsInfluenza TrialsAll Conditions →

Ready to Join in Tucson?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · Tucson, AZ